SEATTLE – Providing immune cell testing and HIV treatment counseling immediately after a positive HIV test was the first in a series of measures that increased rapid linkage to care and retention at ten clinic sites in  Mozambique, data presented here Thursday showed. Measures in a randomized trial of interventions in Maputo and Inhambane Province also […]

Findings from first three of 13 countries in the Population-based HIV Impact Assessment show significant progress, highlight need for focused outreach SEATTLE – Zambia, Zimbabwe and Malawi, neighboring countries all hit hard by HIV across their populations, have all made similar strides that go beyond dropping numbers of new infections to rising numbers of people getting the […]

Continued success of three-drug, six-month regimen introduces potential first gold standard of XDR-TB care SEATTLE – With a mortality rate of about 75 percent, tuberculosis that is extensively resistant to first and second-line treatments — XDR-TB — has left physicians with little choice aside from what Dr. Francesca Conradie calls the “kitchen sink” approach. That […]

SEATTLE – At CROI 2015 the results of the TEMPRANO trial showed that early initiation of antiretroviral therapy and six months of isoniazid preventive therapy significantly reduced illness including tuberculosis in patients with HIV.  On Wednesday, Anani Badje from the TEMPRANO group provided long-term follow-up results from this same study that confirmed the value of […]